Correlation Between CTi Biopharma and Geron
Can any of the company-specific risk be diversified away by investing in both CTi Biopharma and Geron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTi Biopharma and Geron into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CTi Biopharma Corp and Geron, you can compare the effects of market volatilities on CTi Biopharma and Geron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTi Biopharma with a short position of Geron. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTi Biopharma and Geron.
Diversification Opportunities for CTi Biopharma and Geron
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between CTi and Geron is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding CTi Biopharma Corp and Geron in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Geron and CTi Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTi Biopharma Corp are associated (or correlated) with Geron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Geron has no effect on the direction of CTi Biopharma i.e., CTi Biopharma and Geron go up and down completely randomly.
Pair Corralation between CTi Biopharma and Geron
If you would invest 909.00 in CTi Biopharma Corp on September 13, 2024 and sell it today you would earn a total of 0.00 from holding CTi Biopharma Corp or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 4.55% |
Values | Daily Returns |
CTi Biopharma Corp vs. Geron
Performance |
Timeline |
CTi Biopharma Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Geron |
CTi Biopharma and Geron Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CTi Biopharma and Geron
The main advantage of trading using opposite CTi Biopharma and Geron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTi Biopharma position performs unexpectedly, Geron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Geron will offset losses from the drop in Geron's long position.CTi Biopharma vs. Rigel Pharmaceuticals | CTi Biopharma vs. Fortress Biotech | CTi Biopharma vs. Reviva Pharmaceuticals Holdings | CTi Biopharma vs. Protalix Biotherapeutics |
Geron vs. Viking Therapeutics | Geron vs. TG Therapeutics | Geron vs. X4 Pharmaceuticals | Geron vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |